Reports for SUN PHARMA CANADA INC
Company Name
SUN PHARMA CANADA INC
Totals |
||
Shortage reports |
359 |
|
| Actual shortage: | 30 (8%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 6 (2%) | |
| Resolved: | 323 (90%) | |
Discontinuation Reports |
33 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 33 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
208 (53%) |
|
Overdue reports |
16 (53%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TARO-ROSUVASTATIN | 5MG | TABLET | Resolved | 2020-01-28 | 2020-07-03 | 104612 |
| TARO-ROSUVASTATIN | 5MG | TABLET | Resolved | 2021-01-31 | 2021-05-04 | 132997 |
| TARO-ROSUVASTATIN | 5MG | TABLET | Resolved | 2023-08-24 | 2024-01-05 | 202875 |
| TARO-ROSUVASTATIN | 5MG | TABLET | Resolved | 2023-08-24 | 2024-01-05 | 202878 |
| TARO-ROSUVASTATIN | 10MG | TABLET | Resolved | 2019-10-21 | 2020-03-07 | 96901 |
| TARO-ROSUVASTATIN | 10MG | TABLET | Resolved | 2019-10-21 | 2020-04-14 | 96908 |
| TARO-ROSUVASTATIN | 10MG | TABLET | Resolved | 2021-05-01 | 2021-05-04 | 138518 |
| TARO-ROSUVASTATIN | 10MG | TABLET | Resolved | 2023-08-24 | 2024-01-05 | 202881 |
| TARO-ROSUVASTATIN | 10MG | TABLET | Resolved | 2023-08-24 | 2024-01-05 | 202884 |
| TARO-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-11-01 | 2020-07-03 | 97750 |
| TARO-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-11-08 | 2020-03-30 | 98312 |
| TARO-ROSUVASTATIN | 20MG | TABLET | Resolved | 2021-01-31 | 2021-06-16 | 133000 |
| TARO-ROSUVASTATIN | 20MG | TABLET | Resolved | 2021-05-01 | 2021-05-04 | 138521 |
| TARO-ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-01-10 | 2023-02-01 | 180612 |
| TARO-ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-08-24 | 2024-01-05 | 202889 |
| TARO-ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-08-24 | 2024-01-05 | 202893 |
| TARO-ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-10-25 | 2024-01-05 | 208126 |
| TARO-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-01-04 | 2020-04-04 | 102366 |
| TARO-ROSUVASTATIN | 40MG | TABLET | Resolved | 2021-01-31 | 2021-06-16 | 133003 |
| TARO-ROSUVASTATIN | 40MG | TABLET | Resolved | 2021-01-31 | 2021-06-16 | 133006 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TARO-AMLODIPINE | 5MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115038 |
| TARO-AMLODIPINE | 5MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115046 |
| TARO-AMLODIPINE | 10MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115049 |
| TARO-AMLODIPINE | 10MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115052 |
| TARO-CLARITHROMYCIN | 250MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115059 |
| TARO-CLARITHROMYCIN | 500MG | TABLET | Discontinued | 2020-02-02 | 2020-02-02 | 105091 |
| TARO-DONEPEZIL | 5MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80060 |
| TARO-DONEPEZIL | 10MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80063 |
| TARO-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-08-09 | 2019-08-10 | 91261 |
| TARO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-08-09 | 2019-08-10 | 91266 |
| TARO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-08-09 | 2019-08-10 | 91269 |
| TARO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80025 |
| TARO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80028 |
| TARO-PANTOPRAZOLE | Discontinued | 2019-03-29 | 2019-03-29 | 80057 | ||
| TARO-PREGABALIN | 225MG | CAPSULE | Discontinued | 2019-10-04 | 2019-10-04 | 95487 |
| TARO-PREGABALIN | 300MG | CAPSULE | Discontinued | 2020-05-27 | 2020-05-27 | 115811 |
| TARO-QUETIAPINE | 25MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80031 |
| TARO-QUETIAPINE | 25MG | TABLET | Discontinued | 2020-03-07 | 2020-03-07 | 108133 |
| TARO-QUETIAPINE | 100MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80034 |
| TARO-QUETIAPINE | 100MG | TABLET | Discontinued | 2020-03-07 | 2020-03-07 | 108136 |